Jong Sil Kim

Title: Jong Sil Kim and Pharmaceutical Formulation Innovation

Introduction

Jong Sil Kim is an inventor associated with Gyeonggi-do, South Korea, and Dong Kook Pharm. Co., Ltd. His patent work concerns a pharmaceutical composition combining tadalafil and dutasteride, with specified dissolution characteristics for both active ingredients.

Latest Patents

The listed patent is titled “Pharmaceutical composition comprising tadalafil or pharmaceutically acceptable salt thereof and dutasteride or pharmaceutically acceptable salt thereof exhibiting novel dissolution rate.” It describes a composition containing 5 mg of tadalafil, or a pharmaceutically acceptable salt, and 0.5 mg of dutasteride, or a pharmaceutically acceptable salt.

The patent specifies that tadalafil dissolves at a rate of 60–75% after five minutes and at least 80% after 30 minutes under stated paddle, volume, pH, and surfactant conditions. It also specifies that dutasteride dissolves at least 50% after 15 minutes and at least 85% after 30 minutes under its stated test conditions. The supplied information lists 1 patent for Kim.

Career Highlights

Kim’s listed invention focuses on the formulation and dissolution performance of a combination pharmaceutical product. His company affiliation is Dong Kook Pharm. Co., Ltd.

Collaborations

The supplied information identifies Sung Hoon Jun and Ye Ri Lee as Kim’s coworkers. Their names are associated with his professional context, though specific roles in the patent are not provided.

Conclusion

Jong Sil Kim’s listed patent addresses a tadalafil-and-dutasteride composition with defined dissolution targets, reflecting a focused contribution to pharmaceutical formulation innovation.